<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>APHS &#187; Other</title>
	<atom:link href="http://www.aphs.com.au/index.php/news/category/other/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.aphs.com.au</link>
	<description>Australian Pharmaceutical Healthcare Systems</description>
	<lastBuildDate>Tue, 10 Aug 2010 00:14:02 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Pharmacist Entrepreneur Recognised</title>
		<link>http://www.aphs.com.au/index.php/news/2010/08/203/</link>
		<comments>http://www.aphs.com.au/index.php/news/2010/08/203/#comments</comments>
		<pubDate>Mon, 09 Aug 2010 23:51:40 +0000</pubDate>
		<dc:creator>osteele</dc:creator>
				<category><![CDATA[Other]]></category>

		<guid isPermaLink="false">http://www.aphs.com.au/?p=203</guid>
		<description><![CDATA[APHS Managing Partner &#38; Group CEO, Stuart Giles, named regional winner in Ernst &#38; Young Entrepreneur Of The Year
APHS is pleased to announce that Stuart Giles, APHS Managing Partner &#38; Group CEO, has been named a regional winner in the 2010 Ernst &#38; Young Entrepreneur Of The Year awards. Stuart joins other outstanding entrepreneurs from [...]]]></description>
			<content:encoded><![CDATA[<p align="left"><strong>APHS Managing Partner &amp; Group CEO, Stuart Giles, named regional winner in Ernst &amp; Young Entrepreneur Of The Year</strong></p>
<p align="left">APHS is pleased to announce that Stuart Giles, APHS Managing Partner &amp; Group CEO, has been named a regional winner in the 2010 Ernst &amp; Young Entrepreneur Of The Year awards. Stuart joins other outstanding entrepreneurs from across Australia who will compete for the ultimate prize of being named 2010 Ernst &amp; Young Entrepreneur Of The Year.</p>
<p align="left">Like most young boys, a baggy green cap was the pinnacle of Stuart’s youthful aspirations. However, age (and insufficient talent!) saw Stuart cast his boyhood dreams aside and go on to carve an impressive career in pharmacy management. Taking the reins of an organisation firmly entrenched in hospital pharmacy gave Stuart the opportunity to apply his passion for healthcare, innovation and a natural aptitude for financial viability. With APHS’ major private hospital client shifting to an<br />
in-house pharmacy model, Stuart was faced with the ultimate sustainability challenge &#8211; innovate APHS in order to grow or risk watching the organisation wither and die. Repositioning APHS at the forefront of specialist oncology pharmacy and automated medication compliance took leadership and courage, and it was these qualities that caught the eye of Ernst &amp; Young’s Entrepreneur Of The Year judging panel. In an industry that rarely gets credit for being entrepreneurial, Stuart is certainly one of the success stories. </p>
<p align="left">Stuart will join his fellow regional winners at the national award ceremony in Sydney on 24 November 2010.</p>
<p align="left">For media queries regarding Stuart Giles&#8217; win please contact Jenny Scott, Brand &amp; Communications Manager, on 07 3347 9526.</p>
<p><strong>About Ernst &amp; Young Entrepreneur Of The Year:<br />
</strong></p>
<p align="left">Ernst &amp; Young Entrepreneur Of The Year<sup>®</sup> is the world’s most prestigious business award for entrepreneurs. The unique award makes a difference through the way it encourages entrepreneurial activity among those with potential, and recognises the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognising them through regional, national and global awards programs in more than 135 cities in 50 countries. Further information about the Ernst &amp; Young Entrepreneur Of The Year program can be found on their <a href="http://eoy.ey.com.au/" target="_blank">website</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.aphs.com.au/index.php/news/2010/08/203/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>APHS Circuit: June 2010</title>
		<link>http://www.aphs.com.au/index.php/news/2010/06/aphs-circuit-june-2010/</link>
		<comments>http://www.aphs.com.au/index.php/news/2010/06/aphs-circuit-june-2010/#comments</comments>
		<pubDate>Wed, 30 Jun 2010 00:08:10 +0000</pubDate>
		<dc:creator>osteele</dc:creator>
				<category><![CDATA[Other]]></category>

		<guid isPermaLink="false">http://www.aphs.com.au/?p=210</guid>
		<description><![CDATA[Clinical initatives, research and current updates in treatment
View the latest APHS Circuit for relevant clinical information on:
Management of postmenopausal osteoporosis (PMO): something new on the horizon?
Antiplatelet Therapy
The Serotonin Syndrome
A new Drug Brief
]]></description>
			<content:encoded><![CDATA[<p><strong>Clinical initatives, research and current updates in treatment</strong></p>
<p>View the latest <a href="http://www.aphs.com.au/wp-content/uploads/2010/08/circuit_june10.pdf" target="_blank">APHS Circuit</a> for relevant clinical information on:</p>
<li>Management of postmenopausal osteoporosis (PMO): something new on the horizon?</li>
<li>Antiplatelet Therapy</li>
<li>The Serotonin Syndrome</li>
<li>A new Drug Brief</li>
]]></content:encoded>
			<wfw:commentRss>http://www.aphs.com.au/index.php/news/2010/06/aphs-circuit-june-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ShortCircuit: Recall Metronidazole Sandoz IV 500mg/100ml Injection Solution Bag</title>
		<link>http://www.aphs.com.au/index.php/news/2010/06/shortcircuit-recall-metronidazole-sandoz-iv-500mg100ml-injection-solution-bag/</link>
		<comments>http://www.aphs.com.au/index.php/news/2010/06/shortcircuit-recall-metronidazole-sandoz-iv-500mg100ml-injection-solution-bag/#comments</comments>
		<pubDate>Tue, 08 Jun 2010 01:01:05 +0000</pubDate>
		<dc:creator>osteele</dc:creator>
				<category><![CDATA[Other]]></category>

		<guid isPermaLink="false">http://www.aphs.com.au/?p=160</guid>
		<description><![CDATA[Sandoz Pty Ltd have advised that all batches of Metronidazole Sandoz IV 500mg/100ml Injection Solution Bag are being recalled. This is due to a potential lack of assurance sterility.
For more details please read the following recall statement. For APHS pharmacy purposes only, please use the attached return authority.
]]></description>
			<content:encoded><![CDATA[<p>Sandoz Pty Ltd have advised that all batches of Metronidazole Sandoz IV 500mg/100ml Injection Solution Bag are being recalled. This is due to a potential lack of assurance sterility.</p>
<p>For more details please read the following <a href="http://www.aphs.com.au/wp-content/uploads/2010/06/Recall-Notice-080610.pdf" target="_blank">recall statement</a>. For APHS pharmacy purposes only, please use the attached <a href="http://www.aphs.com.au/wp-content/uploads/2010/06/Recall-Fax-080610.pdf" target="_blank">return authority</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.aphs.com.au/index.php/news/2010/06/shortcircuit-recall-metronidazole-sandoz-iv-500mg100ml-injection-solution-bag/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>APHS News: April 2010</title>
		<link>http://www.aphs.com.au/index.php/news/2010/04/aphs-news-april-2010/</link>
		<comments>http://www.aphs.com.au/index.php/news/2010/04/aphs-news-april-2010/#comments</comments>
		<pubDate>Fri, 30 Apr 2010 00:13:50 +0000</pubDate>
		<dc:creator>osteele</dc:creator>
				<category><![CDATA[Other]]></category>

		<guid isPermaLink="false">http://www.aphs.com.au/?p=217</guid>
		<description><![CDATA[Please view APHS News for all the latest updates.
]]></description>
			<content:encoded><![CDATA[<p>Please view <a href="http://www.aphs.com.au/wp-content/uploads/2010/08/aphs_news_APR10_v03.pdf" target="_blank">APHS News</a> for all the latest updates.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.aphs.com.au/index.php/news/2010/04/aphs-news-april-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Short Circuit: Cefazolin Sandoz 1g 10 Vials</title>
		<link>http://www.aphs.com.au/index.php/news/2009/11/short-circuit-cefazolin-sandoz-1g-10-vials/</link>
		<comments>http://www.aphs.com.au/index.php/news/2009/11/short-circuit-cefazolin-sandoz-1g-10-vials/#comments</comments>
		<pubDate>Mon, 09 Nov 2009 03:02:56 +0000</pubDate>
		<dc:creator>osteele</dc:creator>
				<category><![CDATA[Other]]></category>

		<guid isPermaLink="false">http://www.aphs.com.au/?p=148</guid>
		<description><![CDATA[Due to reports of anaphylaxis potentially associated with batch AH5067, there is an urgent recall on Cefazolin Sandoz 1g 10 Vials. Please see the recall notice for further details.
]]></description>
			<content:encoded><![CDATA[<p>Due to reports of anaphylaxis potentially associated with batch <strong>AH5067</strong>, there is an urgent recall on Cefazolin Sandoz 1g 10 Vials. Please see the <a href="http://www.aphs.com.au/wp-content/uploads/2009/11/Recall-Cefazolin-Sandoz-1g.pdf" target="_blank">recall notice</a> for further details.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.aphs.com.au/index.php/news/2009/11/short-circuit-cefazolin-sandoz-1g-10-vials/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ShortCircuit: Recall Xylocaine 4% Topical Solution</title>
		<link>http://www.aphs.com.au/index.php/news/2009/10/shortcircuit-recall-xylocaine-4-topical-solution/</link>
		<comments>http://www.aphs.com.au/index.php/news/2009/10/shortcircuit-recall-xylocaine-4-topical-solution/#comments</comments>
		<pubDate>Wed, 14 Oct 2009 08:01:11 +0000</pubDate>
		<dc:creator>osteele</dc:creator>
				<category><![CDATA[Other]]></category>

		<guid isPermaLink="false">http://www.aphs.com.au/?p=144</guid>
		<description><![CDATA[
 

After consultation with the Therapeutic Goods Administration, AstraZeneca is conducting a sponsor-initiated recall of two batches of Xylocaine 4% Topical Solution 30mL bottle packs of 1, batch numbers 1294883 and 1299209. The recall is being undertaken because AstraZeneca has determined that the fill volume in some bottles is slightly higher than the in process specification [...]]]></description>
			<content:encoded><![CDATA[<div><span style="font-size: small; font-family: Arial;"></span></div>
<p> </p>
<p><span style="font-size: small; font-family: Arial;"></p>
<p align="left">After consultation with the Therapeutic Goods Administration, AstraZeneca is conducting a sponsor-initiated recall of two batches of Xylocaine <strong>4% </strong>Topical Solution 30mL bottle packs <strong>of 1, </strong>batch numbers 1294883 and 1299209. The recall is being undertaken because AstraZeneca has determined that the fill volume in some bottles is slightly higher than the in process specification resulting in the active ingredient assays being below the registered specification.</p>
<p align="left">For more details please read the following <a href="http://www.aphs.com.au/wp-content/uploads/2009/10/Recall-Notice-131009.pdf" target="_blank">recall statement</a>. For APHS pharmacy purposes only, please use the attached <a href="http://www.aphs.com.au/wp-content/uploads/2009/10/AstraZeneca-CUSTOMER-PRODUCT-RECALL-121009.doc" target="_blank">return authority</a>.</p>
<p align="left"> </p>
<p> </p>
<p></span></p>
]]></content:encoded>
			<wfw:commentRss>http://www.aphs.com.au/index.php/news/2009/10/shortcircuit-recall-xylocaine-4-topical-solution/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HealthVax acquired and enjoys tender Success!</title>
		<link>http://www.aphs.com.au/index.php/news/2008/05/healthvax-acquired-and-enjoys-tender-success/</link>
		<comments>http://www.aphs.com.au/index.php/news/2008/05/healthvax-acquired-and-enjoys-tender-success/#comments</comments>
		<pubDate>Thu, 08 May 2008 05:51:40 +0000</pubDate>
		<dc:creator>osteele</dc:creator>
				<category><![CDATA[Other]]></category>

		<guid isPermaLink="false">http://www.aphs.com.au/?p=105</guid>
		<description><![CDATA[Influenza doesn&#8217;t recognise State borders, so we are delighted to announce that APHS through its Home Therapeutics brand recently acquired the HealthVax business under which our vaccination business will expand nationally. HealthVax, an established Victorian brand, gives us a strong base from which to market our vaccination services to the Southern States.
The first early success [...]]]></description>
			<content:encoded><![CDATA[<p>Influenza doesn&#8217;t recognise State borders, so we are delighted to announce that APHS through its Home Therapeutics brand recently acquired the HealthVax business under which our vaccination business will expand nationally. HealthVax, an established Victorian brand, gives us a strong base from which to market our vaccination services to the Southern States.</p>
<p>The first early success we celebrated was an important tender win last month, being selected as the successful influenza vaccinator provider for Sydney Buses, Newcastle Buses and Western Sydney Buses.</p>
<p>The 3 year contract includes the administering of Influenza Vaccinations which is offered to several thousand staff. Andrew Wells, APHS Regional Manager South Eastern Australia noted that, &#8220;There are also some requirements for Hepatitis B Vaccinations and post-vaccination serological testing to ascertain if the Hepatitis B Vaccinations have elicited a positive response.&#8221;</p>
<p>A delighted Darryl Grundy added, &#8220;This is a significant breakthrough for the HealthVax brand operating under Home Therapeutics, giving it a strong foothold in NSW to explore further opportunities from.&#8221;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.aphs.com.au/index.php/news/2008/05/healthvax-acquired-and-enjoys-tender-success/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>APHS launches new web site</title>
		<link>http://www.aphs.com.au/index.php/news/2008/05/aphs-launches-new-web-site/</link>
		<comments>http://www.aphs.com.au/index.php/news/2008/05/aphs-launches-new-web-site/#comments</comments>
		<pubDate>Thu, 01 May 2008 06:23:09 +0000</pubDate>
		<dc:creator>osteele</dc:creator>
				<category><![CDATA[Other]]></category>

		<guid isPermaLink="false">http://www.aphs.com.au/?p=97</guid>
		<description><![CDATA[Welcome to the new APHS website and thank you for visiting us. We&#8217;ve designed the site to be more interactive and tried to make it easier for you to find out the information you need.
We look forward to getting to know you.
]]></description>
			<content:encoded><![CDATA[<p>Welcome to the new APHS website and thank you for visiting us. We&#8217;ve designed the site to be more interactive and tried to make it easier for you to find out the information you need.</p>
<p>We look forward to getting to know you.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.aphs.com.au/index.php/news/2008/05/aphs-launches-new-web-site/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Advisory Board update</title>
		<link>http://www.aphs.com.au/index.php/news/2008/04/advisory-board-update/</link>
		<comments>http://www.aphs.com.au/index.php/news/2008/04/advisory-board-update/#comments</comments>
		<pubDate>Tue, 29 Apr 2008 05:22:45 +0000</pubDate>
		<dc:creator>osteele</dc:creator>
				<category><![CDATA[Other]]></category>

		<guid isPermaLink="false">http://www.aphs.com.au/?p=89</guid>
		<description><![CDATA[The APHS Advisory Board held its inaugural meeting over the Australian Pharmacy Professional Conference (APP) weekend on the Gold Coast in March. The new Board which will oversee the long term strategy and direction of APHS and provide Governance began with an overview of the business and coming challenges and opportunities.
 
Its members include Tom, Cathie [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.aphs.com.au/wp-content/uploads/2008/04/bruce-annabel1.jpg"><img class="alignright size-medium wp-image-88" title="bruce annabel" src="http://www.aphs.com.au/wp-content/uploads/2008/04/bruce-annabel1-180x300.jpg" alt="Bruce Annabel, APHS Advisory Board" width="180" height="300" /></a>The APHS Advisory Board held its inaugural meeting over the Australian Pharmacy Professional Conference (APP) weekend on the Gold Coast in March. The new Board which will oversee the long term strategy and direction of APHS and provide Governance began with an overview of the business and coming challenges and opportunities.<span id="more-89"></span></p>
<p> </p>
<p>Its members include Tom, Cathie &amp; Stuart representing the APHS Partner Group together with John Jackson, Group Director of the Pharmacy Practice Unit and Chris Attard in his executive role of GM Finance, Information Systems and Logistics.</p>
<p> </p>
<p>Two independent appointments have been made to balance the Board&#8217;s make up. Annette Schmiede brings a wealth of experience in Australia&#8217;s health and aged care sectors. With a career spanning three decades, she has a deep knowledge of the structure, funding and policy framework of health and aged care in Australia and is conversant with the major issues confronting these industries. Annette has worked extensively with the Catholic Health Care sector and most recently was Chairman of St John of God Health Services from 2003 to 2007.</p>
<p> </p>
<p>Joining Annette is Bruce Annabel, a well known and respected Pharmacy Industry figure. Founding Partner of JR Pharmacy Services, a division of JR Chartered Accountants, Bruce is the leading authority on the financial and strategic planning aspects of community pharmacy and the integration of these into the development of a unique healthcare service proposition. Bruce has had a long term strategic involvement with APHS and the Advisory Board is a fantastic vehicle to formalise this role.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.aphs.com.au/index.php/news/2008/04/advisory-board-update/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
